NathanJRobisonMD

Clinical Trials

• Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG) Start of enrollment: 2011 Sep 01

  Terminated

  Phase 2

• MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1 Start of enrollment: 2014 Jun 01

  Completed

  Phase 2

• A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration Start of enrollment: 2020 Jan 17

  Recruiting

  Phase 1, Phase 2

  Roles: Contact, Principal Investigator

• Phase I Study of APX005M in Pediatric CNS Tumors Start of enrollment: 2018 Mar 01

  Active, not recruiting

  Phase 1

  Roles: Contact, Principal Investigator

• Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG Start of enrollment: 2017 Apr 04

  Recruiting

  Not Applicable

  Roles: Contact, Principal Investigator

• Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery Start of enrollment: 2019 Jul 25

  Suspended

  Phase 1, Phase 2

  Roles: Contact

• A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma Start of enrollment: 2022 Jul 01

  Recruiting

  Phase 1

  Roles: Principal Investigator, Contact

• Expanded Access to OKN-007 for Patients With Diffuse Midline Glioma, H3 K27-altered

  Available

  Roles: Principal Investigator, Contact

• Join now to see all